We are live on
!
Find out more
KIC
Kensington Investment Counsel Portfolio holdings
AUM
$208M
1-Year Est. Return
11.99%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+11.99%
3 Year Est. Return
+61.57%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$5.21M
(+4.1%)
Cap. Flow
-$2.26M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
29.71%
Holding
84
New
3
Increased
21
Reduced
55
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AvalonBay Communities
AVB
|
+$821K |
| 2 |
Broadridge
BR
|
+$808K |
| 3 |
Home Depot
HD
|
+$345K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$327K |
| 5 |
Accenture
ACN
|
+$317K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$475K |
| 2 |
AbbVie
ABBV
|
+$426K |
| 3 |
Novartis
NVS
|
+$366K |
| 4 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$342K |
| 5 |
Clorox
CLX
|
+$330K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.01% |
| 2 | Healthcare | 18.07% |
| 3 | Industrials | 16.2% |
| 4 | Consumer Staples | 11.36% |
| 5 | Consumer Discretionary | 10.07% |
Similar funds
HCA
FHWM
SNBOSD
MIP
SG
MPCG
MCP
EPG
Kensington Investment Counsel's Q1 2023 Portfolio in Review
As of Q1 2023, Kensington Investment Counsel held 84 positions worth $132M, up 4.1% from $127M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.8%. Kensington Investment Counsel opened 3 new positions and exited 1, leaving the 84-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
- Kensington Investment Counsel's largest Q1 2023 buy was AvalonBay Communities: 4,815 shares worth $809K.
- Kensington Investment Counsel added most to Home Depot in Q1 2023, an estimated $345K increase.
- Kensington Investment Counsel's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $475K.
- Kensington Investment Counsel fully exited Concert Pharmaceuticals, Inc. in Q1 2023, selling an estimated $342K.
- Kensington Investment Counsel's ten largest holdings make up 30% of its $132M portfolio in Q1 2023.
- Kensington Investment Counsel opened 3 new positions and closed 1 in Q1 2023.
- Kensington Investment Counsel's portfolio value rose 4.1% quarter-over-quarter to $132M.
Based on Kensington Investment Counsel's 13F filing for Q1 2023, filed 11 May 2023.